BioCentury
ARTICLE | Financial News

Aileron raises $30 million series E

November 19, 2013 1:56 AM UTC

Aileron Therapeutics Inc. (Cambridge, Mass.) raised $30 million in a series E round. All of the company's existing investors participated, including Apple Tree Partners; Roche Venture Fund; Novartis Venture Funds; Lilly Ventures; SR One; and Excel Venture Management. Additionally, Scott Kapnick, CEO of Highbridge Capital, was named chairman of Aileron. ...